of dienynes was investigated using cobalt-based catalysts. Substrates without substitution on alkyne moiety were found to react under thermal activation. The use of a cobalt salt as catalyst made reactions cleaner by limiting the formation of byproducts. Cycloadditions with dienynes possessing a substituent on the alkyne pattern occurred only in presence of a cobalt catalyst which displayed a moderate
INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL
申请人:Merck Sharp & Dohme Corp.
公开号:EP2956142B1
公开(公告)日:2017-09-20
SPIROCYCLE COMPOUNDS AND METHODS OF MAKING AND USING SAME
申请人:Abide Therapeutics, Inc.
公开号:US20170327500A1
公开(公告)日:2017-11-16
Provided herein are spirocycle compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful as modulators of MAGL and/or ABHD6. Furthermore, the subject compounds and compositions are useful for the treatment of pain.
Rhodium catalysed [2+2+2] cycloadditions of acetylenes